Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancers|June 2, 2021
Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?Klara Klein, Dagmar Stoiber, Veronika Sexl, et al.
Frontiers in Immunology|July 22, 2022
The Multifaceted Role of STAT3 in NK-Cell Tumor SurveillanceAgnieszka Witalisz-Siepracka, Klara Klein, Bernhard Zdársky, et al.
BMJ Case Reports|January 5, 2018
Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administrationKlara Klein, Shonda Asaad, Michael Econs, et al.
Frontiers in Immunology|January 24, 2019
Loss of JAK1 Drives Innate Immune DeficiencyAgnieszka Witalisz-Siepracka, Klara Klein, Daniela Prinz, et al.
BMC Veterinary Research|March 2, 2025
Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisationUlrike Lessiak, Tania Brandstoetter, Barbara Nell, et al.
Frontiers in Immunology|December 17, 2021
A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like ReceptorsKlara Klein, Angelique Hölzemer, Tim Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2025
Langerhans cell-targeted protein delivery enhances antigen-specific cellular immune responseRamona Rica, Klara Klein, Litty Johnson, et al.
Frontiers in Immunology|July 12, 2021
T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses <i>In Vivo</i>Klara Klein, Agnieszka Witalisz-Siepracka, Dagmar Gotthardt, et al.
Cell|February 7, 2017
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic RasTim Wang, Haiyan Yu, Nicholas W Hughes, et al.
Cell Death & Disease|October 24, 2021
Triple-negative breast cancer cells rely on kinase-independent functions of CDK8 to evade NK-cell-mediated tumor surveillanceVanessa Maria Knab, Dagmar Gotthardt, Klara Klein, et al.
Pageof 2